Zobrazeno 1 - 10
of 213
pro vyhledávání: '"Wouter V, Vogel"'
Autor:
Hinke Siebinga, Berlinda J. de Wit-van der Veen, Daphne M. V. de Vries-Huizing, Wouter V. Vogel, Jeroen J. M. A. Hendrikx, Alwin D. R. Huitema
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-24 (2024)
Abstract Background There is an unmet need for prediction of treatment outcome or patient selection for [177Lu]Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer (mCRPC). Quantification of the tumor exposure–response r
Externí odkaz:
https://doaj.org/article/8fff240eb4dd480799fca12f85a0fb21
Autor:
Esmée C. A. van der Sar, Arthur J. A. T. Braat, Jochem R. N. van der Voort- van Zyp, Betty S. van der Veen, Pim J. van Leeuwen, Daphne M. V. de Vries-Huizing, Jeroen M. A. Hendrikx, Marnix G. E. H. Lam, Wouter V. Vogel
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Prostate cancer patients with locoregional lymph node disease at diagnosis (N1M0) still have a limited prognosis despite the improvements provided by aggressive curative intent multimodal locoregional external beam radiation thera
Externí odkaz:
https://doaj.org/article/dac90973c6854e54a9c076eb027a63e9
Autor:
Hilda A. de Barros, Jan J. Duin, Daan Mulder, Vincent van der Noort, M. Arjen Noordzij, Esther M.K. Wit, Floris J. Pos, Wouter V. Vogel, Eva E. Schaake, Fijs W.B. van Leeuwen, Pim J. van Leeuwen, Nikolaos Grivas, Henk G. van der Poel
Publikováno v:
European Urology Open Science, Vol 49, Iss , Pp 80-89 (2023)
Background: Accurate identification of men who harbor nodal metastases is necessary to select patients who most likely benefit from whole pelvis radiotherapy (WPRT). Limited sensitivity of diagnostic imaging approaches for the detection of nodal micr
Externí odkaz:
https://doaj.org/article/f9255bdaee584a7bb5c56c0bf65545d6
Autor:
Abrahim Al-Mamgani, Rob Kessels, Zeno A.R. Gouw, Arash Navran, Vineet Mohan, Jeroen B. van de Kamer, Jan-Jakob Sonke, Wouter V. Vogel
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 43, Iss , Pp 100676- (2023)
Purpose: To report on the late toxicity and local control (LC) of head and neck cancer patients treated with adaptive FDG-PET/CT response-guided radiotherapy (ADMIRE) with dose escalation (NCT03376386). Materials and methods: Between December 2017 an
Externí odkaz:
https://doaj.org/article/d6644157a80542b688e72520d55079df
Autor:
Maarten L. Donswijk, Maurits Wondergem, Linda de Wit - van der Veen, Natascha M. Bruin, Pim J. van Leeuwen, Henk G. van der Poel, Marcel P. M. Stokkel, Wouter V. Vogel
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Background High urinary activity in urinary bladder and ureters may hamper interpretation of prostate cancer and regional nodal metastases in prostate-specific membrane antigen (PSMA) PET/CT. The goal of this study was to assess effects of f
Externí odkaz:
https://doaj.org/article/9b8e262db5ef405abbf80f3558197b68
Autor:
Joris L. Vos, Joris B. W. Elbers, Oscar Krijgsman, Joleen J. H. Traets, Xiaohang Qiao, Anne M. van der Leun, Yoni Lubeck, Iris M. Seignette, Laura A. Smit, Stefan M. Willems, Michiel W. M. van den Brekel, Richard Dirven, M. Baris Karakullukcu, Luc Karssemakers, W. Martin C. Klop, Peter J. F. M. Lohuis, Willem H. Schreuder, Ludi E. Smeele, Lilly-Ann van der Velden, I. Bing Tan, Suzanne Onderwater, Bas Jasperse, Wouter V. Vogel, Abrahim Al-Mamgani, Astrid Keijser, Vincent van der Noort, Annegien Broeks, Erik Hooijberg, Daniel S. Peeper, Ton N. Schumacher, Christian U. Blank, Jan Paul de Boer, John B. A. G. Haanen, Charlotte L. Zuur
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Immune checkpoint blockade has become standard care for patients with recurrent metastatic head and neck squamous cell carcinoma (HNSCC). Here the authors present the results of a non-randomized phase Ib/IIa trial, reporting safety and efficacy of ne
Externí odkaz:
https://doaj.org/article/761c20eac4bf4e0f8dc9495fdeadff61
Autor:
Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Willemijn A. van Gemert, Michel de Groot, Harm Westdorp, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-4 (2021)
Abstract Background The BULLSEYE trial is a multicenter, open-label, randomized controlled trial to test the hypothesis if 177Lu-PSMA is an effective treatment in oligometastatic hormone-sensitive prostate cancer (oHSPC) to prolong the progression-fr
Externí odkaz:
https://doaj.org/article/d0eae2f7bc184b94b9f6863ede0c30e8
Autor:
Charlotte L. Deijen, Gerbert L. Vrijenhoek, Eva E. Schaake, Wouter V. Vogel, Luc M.F. Moonen, Floris J. Pos, Henk G. van der Poel, Gerben R. Borst
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 30, Iss , Pp 1-6 (2021)
Background: In patients with oligometastatic recurrent prostate cancer, standard treatment is androgen deprivation therapy (ADT). However, ADT has many potential side effects that may result in impaired quality of life. Early identification to select
Externí odkaz:
https://doaj.org/article/a11c6f6d205f47ce9d9fe431c1734c4c
Autor:
Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Michel de Groot, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background In recent years, there is increasing evidence showing a beneficial outcome (e.g. progression free survival; PFS) after metastases-directed therapy (MDT) with external beam radiotherapy (EBRT) or targeted surgery for oligometastati
Externí odkaz:
https://doaj.org/article/05ea3477df904c7e9eba15f0eafa2c79
Autor:
Sebastian Sanduleanu, Olga Hamming-Vrieze, Frederik W.R. Wesseling, Aniek J.G. Even, Frank J. Hoebers, Ann Hoeben, Wouter V. Vogel, Margot E.T. Tesselaar, Daniel Parvin, Harry Bartelink, Philippe Lambin
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 23, Iss , Pp 9-15 (2020)
Introduction: The presence of hypoxia in head-and-neck squamous cell carcinoma is a negative prognostic factor. PET imaging with [18F] HX4 can be used to visualize hypoxia, but it is currently unknown how this correlates with prognosis. We investigat
Externí odkaz:
https://doaj.org/article/d9a3b671d96f4c17aa089c7149312cae